October Tessie W, Schleien Charles L, Berg Robert A, Nadkarni Vinay M, Morris Marilyn C
College of Physicians and Surgeons, Columbia University, New York, NY, USA.
Crit Care Med. 2008 Jan;36(1):126-30. doi: 10.1097/01.CCM.0000295592.97331.5A.
To examine practice patterns of amiodarone use during in-hospital cardiac arrest. This study addresses the changing pattern of amiodarone use over time, following the publication of landmark studies and the inclusion of amiodarone in the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Furthermore, this study examines the impact of hospital and patient specific factors on the use of amiodarone.
Retrospective cohort study, using the National Registry for Cardiopulmonary Resuscitation, an international registry of in-hospital resuscitation events.
All patients with an in-hospital ventricular fibrillation (VF) or pulseless ventricular tachycardia (pVT) event reported to the national registry from January 1, 2000, to July 31, 2005.
During the study period, 14,854 of 29,552 (50%) adults (> 18 yrs old) with VF/pVT received an antiarrhythmic drug; 8,883 (60%) of these patients received amiodarone. In adults, amiodarone use for VF/pVT increased from 25% in 2000 to 72% in 2005 (p < .0001). Among children, 270 of 553 (49%) VF/pVT episodes were treated with an antiarrhythmic drug; 108 (40%) of these patients received amiodarone. Adults in institutions with larger intensive care units (> 50 beds) were more likely than those in institutions with smaller intensive care units (< or = 50 beds) to receive amiodarone; the association persisted in multivariable analysis (odds ratio [OR] = 1.825; 95% confidence interval [CI], 1.694-1.966). Thirty five percent of adults with VF/pVT who received amiodarone also received lidocaine, while 67% of children who received amiodarone also received lidocaine (p < .001). It is not possible to determine from the database the order in which medications were administered.
There has been a significant increase in amiodarone use for VF/pVT events over the past 5 yrs. The frequency of amiodarone use in adults correlated positively with the number of intensive care beds. These results suggest that emerging data and national guidelines affect resuscitation practice patterns.
研究住院心脏骤停期间胺碘酮的使用模式。本研究探讨了里程碑式研究发表以及胺碘酮被纳入美国心脏协会心肺复苏和心血管急救指南后,胺碘酮使用模式随时间的变化情况。此外,本研究还考察了医院和患者特定因素对胺碘酮使用的影响。
回顾性队列研究,使用国家心肺复苏注册系统,这是一个关于住院复苏事件的国际注册系统。
2000年1月1日至2005年7月31日期间向国家注册系统报告的所有住院室颤(VF)或无脉性室性心动过速(pVT)患者。
在研究期间,29552例成人(>18岁)VF/pVT患者中有14854例(50%)接受了抗心律失常药物治疗;其中8883例(60%)患者接受了胺碘酮治疗。在成人中,用于VF/pVT的胺碘酮使用比例从2000年的25%增至2005年的72%(p<.0001)。在儿童中,553例VF/pVT发作中有270例(49%)接受了抗心律失常药物治疗;其中这些患者中有108例(40%)接受了胺碘酮治疗。在重症监护病房规模较大(>50张床位)的机构中的成人比在规模较小(≤50张床位)的机构中的成人更有可能接受胺碘酮治疗;该关联在多变量分析中仍然存在(比值比[OR]=1.825;95%置信区间[CI],1.694 - 1.966)。接受胺碘酮治疗的VF/pVT成人患者中有35%也接受了利多卡因治疗,而接受胺碘酮治疗的儿童患者中有67%也接受了利多卡因治疗(p<.001)。无法从数据库中确定用药顺序。
在过去5年中,用于VF/pVT事件的胺碘酮使用量显著增加。成人中胺碘酮的使用频率与重症监护病床数量呈正相关。这些结果表明,新出现的数据和国家指南会影响复苏实践模式。